Literature DB >> 14511291

Immunization of patients with bleeding disorders.

M Makris1, C P Conlon, H G Watson.   

Abstract

The immunization of patients with bleeding disorders differs from that of the normal population with respect to the risk of haematoma formation at the vaccination site and the unusual infective risks associated with the potential, and past, exposure to blood products. Most vaccinations can be given subcutaneously and this should be the preferred route. All routine childhood vaccinations should be given at the appropriate time. All patients with bleeding disorders should be vaccinated against hepatitis A and B. HIV positive patients should receive annual influenza vaccinations and should avoid the oral polio, oral typhoid, BCG and yellow fever vaccines.

Entities:  

Mesh:

Year:  2003        PMID: 14511291     DOI: 10.1046/j.1365-2516.2003.00819.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  6 in total

1.  Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.

Authors:  Angiola Rocino; Antonio Coppola; Massimo Franchini; Giancarlo Castaman; Cristina Santoro; Ezio Zanon; Elena Santagostino; Massimo Morfini
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

2.  Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a universal data collection database analysis.

Authors:  S L Carpenter; J M Soucie; R J Presley; M V Ragni; B M Wicklund; M Silvey; H Davidson
Journal:  Haemophilia       Date:  2014-11-07       Impact factor: 4.287

Review 3.  Principles of care for the diagnosis and treatment of von Willebrand disease.

Authors:  Giancarlo Castaman; Anne Goodeve; Jeroen Eikenboom
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

Review 4.  Clinical and laboratory approaches to hemophilia a.

Authors:  Hassan Mansouritorghabeh
Journal:  Iran J Med Sci       Date:  2015-05

5.  A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations.

Authors:  Zekun Li; Zhenping Chen; Xiaoling Cheng; Xinyi Wu; Gang Li; Yingzi Zhen; Man-Chiu Poon; Runhui Wu
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

6.  Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project.

Authors:  Elena Santagostino; Agostino Riva; Simone Cesaro; Susanna Esposito; Davide Matino; Renata Ilde Mazzucchelli; Angelo Claudio Molinari; Rosamaria Mura; Lucia Dora Notarangelo; Annarita Tagliaferri; Giovanni Di Minno; Mario Clerici
Journal:  Haemophilia       Date:  2019-04-16       Impact factor: 4.287

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.